Bacteroides fragilis, a Gram-negative anaerobic bacterium, is typically a commensal in the human gut but can become pathogenic under conditions of intestinal dysbiosis. A critical factor in its pathogenicity is the production of Cholesterol-Dependent Cytolysin-Like proteins (CDCLs), a novel class of pore-forming toxins that enable B. fragilis to thrive by targeting and disrupting competing microorganisms in the intestinal environment. Despite their importance, several aspects of CDCL pore formation and regulation remain poorly understood. (1,2)
Our study investigates the structural and functional properties of two CDCL proteins, Bf long and Bf short, from B. fragilis. Interestingly, in addition to the pore-forming proteins, B. fragilis produces BcdI, a surface lipoprotein that confers immunity against its own toxins. A central question is: how do these CDCLs assemble into large, multi-component pores upon proteolytic activation, and what role does BcdI play in regulating their pore-forming activity? (3)
Using an integrated approach of X-ray crystallography, small-angle X-ray scattering (SAXS), and cryo-electron microscopy (cryo-EM), we present the first high-resolution crystal structures of Bf short and BcdI, along with SAXS and cryo-EM models of the CDCL pore complex. Furthermore, we conduct protein functional analysis using liposome rupture and liposome pull-down experiments. These techniques provide critical insights into the interactions between CDCLs and lipid membranes.
Our findings represent a significant advance in understanding the molecular mechanisms underlying pore formation in bacterial toxins and their regulation. Together with our ongoing research, these results contribute to a deeper understanding of the mechanisms behind CDCL pore formation and regulation in B. fragilis, shedding light on how the bacterium exploits these virulence factors to its advantage. This work not only deepens our knowledge of CDCL toxins but also highlights the potential for targeting these mechanisms in therapeutic strategies for microbial diseases.